Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines.

Yamanaka T, Cullinane A, Gildea S, Bannai H, Nemoto M, Tsujimura K, Kondo T, Matsumura T.

Equine Vet J. 2015 Jul;47(4):456-62. doi: 10.1111/evj.12290. Epub 2014 Jun 3.

PMID:
24773030
2.

The molecular epidemiology of equine influenza in Ireland from 2007-2010 and its international significance.

Gildea S, Quinlivan M, Arkins S, Cullinane A.

Equine Vet J. 2012 Jul;44(4):387-92. doi: 10.1111/j.2042-3306.2011.00472.x. Epub 2011 Oct 6.

PMID:
21978127
3.

Vaccine failure caused an outbreak of equine influenza in Croatia.

Barbic L, Madic J, Turk N, Daly J.

Vet Microbiol. 2009 Jan 1;133(1-2):164-71. doi: 10.1016/j.vetmic.2008.06.009. Epub 2008 Jun 12.

PMID:
18632226
4.

Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.

Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J.

Vet Microbiol. 2013 Mar 23;162(2-4):396-407. doi: 10.1016/j.vetmic.2012.10.019. Epub 2012 Oct 24.

PMID:
23146168
5.

Antibody responses induced by Japanese whole inactivated vaccines against equine influenza virus (H3N8) belonging to Florida sublineage clade2.

Yamanaka T, Bannai H, Nemoto M, Tsujimura K, Kondo T, Matsumura T.

J Vet Med Sci. 2011 Apr;73(4):483-5. Epub 2010 Nov 19.

6.

Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012.

Woodward AL, Rash AS, Blinman D, Bowman S, Chambers TM, Daly JM, Damiani A, Joseph S, Lewis N, McCauley JW, Medcalf L, Mumford J, Newton JR, Tiwari A, Bryant NA, Elton DM.

Vet Microbiol. 2014 Mar 14;169(3-4):113-27. doi: 10.1016/j.vetmic.2013.11.039. Epub 2013 Dec 21.

PMID:
24480583
7.

A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.

Gildea S, Arkins S, Walsh C, Cullinane A.

Vaccine. 2011 Nov 15;29(49):9214-23. doi: 10.1016/j.vaccine.2011.09.101. Epub 2011 Oct 5.

PMID:
21983355
8.

Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012).

Gildea S, Fitzpatrick DA, Cullinane A.

Influenza Other Respir Viruses. 2013 Dec;7 Suppl 4:61-72. doi: 10.1111/irv.12192.

9.

Equine influenza vaccine efficacy: the significance of antigenic variation.

Yates P, Mumford JA.

Vet Microbiol. 2000 May 22;74(1-2):173-7.

PMID:
10799789
11.

Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy.

Daly JM, Elton D.

Vaccine. 2013 Dec 9;31(51):6043-5. doi: 10.1016/j.vaccine.2013.06.070. Epub 2013 Jul 2.

12.
13.

The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).

Galvin P, Gildea S, Arkins S, Walsh C, Cullinane A.

Influenza Other Respir Viruses. 2013 Dec;7 Suppl 4:73-80. doi: 10.1111/irv.12195.

14.

Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.

Pouwels HG, Van de Zande SM, Horspool LJ, Hoeijmakers MJ.

Vet Rec. 2014 Jun 21;174(25):633. doi: 10.1136/vr.101993. Epub 2014 May 2.

15.

Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.

Daly JM, Yates PJ, Newton JR, Park A, Henley W, Wood JL, Davis-Poynter N, Mumford JA.

Vaccine. 2004 Sep 28;22(29-30):4101-9.

PMID:
15364463
16.

A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge.

Chambers TM, Holland RE, Tudor LR, Townsend HG, Cook A, Bogdan J, Lunn DP, Hussey S, Whitaker-Dowling P, Youngner JS, Sebring RW, Penner SJ, Stiegler GL.

Equine Vet J. 2001 Nov;33(7):630-6.

PMID:
11770982
17.

Equine influenza - surveillance and control.

Cullinane A, Elton D, Mumford J.

Influenza Other Respir Viruses. 2010 Nov;4(6):339-44. doi: 10.1111/j.1750-2659.2010.00176.x. Review.

18.

The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.

Ryan M, Gildea S, Walsh C, Cullinane A.

Equine Vet J. 2015 Nov;47(6):662-6. doi: 10.1111/evj.12353. Epub 2014 Nov 24.

PMID:
25238593
19.

Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.

Bryant NA, Paillot R, Rash AS, Medcalf E, Montesso F, Ross J, Watson J, Jeggo M, Lewis NS, Newton JR, Elton DM.

Vet Res. 2010 Mar-Apr;41(2):19. doi: 10.1051/vetres/2009067. Epub 2009 Oct 29.

20.

Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.

Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Gildea S, Cullinane A.

Influenza Other Respir Viruses. 2016 Jul 28. doi: 10.1111/irv.12418. [Epub ahead of print]

Items per page

Supplemental Content

Write to the Help Desk